People pose with syringe with needle in front of displayed AstraZeneca logo in this illustration taken, December 11, 2021. REUTERS/Dado Ruvic/Illustration/FilesDrugmaker's shares have outperformed rivals since 2020LONDON, Feb 9 - AstraZeneca
CEO Pascal Soriot said the firm was on a path to deliver at least 15 new medicines this decade. The company also predicted a return to growth in China, one of its key markets, after reporting a second consecutive quarter of growth even as prices remain under pressure.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: